Why become a partner with Proximagen?




Our flexible set-up means that we can work effectively with partners at every stage of development. Our financial resources and R&D capability make Proximagen an attractive partner for companies developing new medicines for patients.


  • Business model for growth based on partnerships

  • Proven execution of win-win deals

  • Strong financial position

  • Reliable and focused attention to our partners





    • We are committed to bringing novel drugs and innovative new treatments as rapidly as possible, bringing new hope to the patients and value to our shareholders.


    Passion for science, simple process and flexible deals.


    Our four-step partnership process is fast, clear and straightforward. From initial discussions to signing the deal, you will find that we are passionate, flexible, creative, and professional.



    Step 1: Making the connection.



    • Our business development team seek out new opportunities
    • Review of non-confidential information



    Step 2: Understanding your technology.



    • After the non-confidential review, a nondisclosure agreement is signed.
    • Confidential information is reviewed



    Step 3: Getting to the deal.



    • Term sheets are negotiated
    • Full due diligence is undertaken
    • Definitive terms are agreed and the contracts signed



    Step 4: Working together as partners.



    • Working together on joint steering committees
    • Implement the collaboration.



    Proximagen considers opportunities at all stages of development, even at very early stages of development or programmes that are in later stages of clinical development. The Proximagen business development team understands the importance of science and business in each partnership and we are interested in reviewing opportunities which match our strategic focus. We will work with you closely throughout the partnering process to create deals which add value for mutual success.